Company performance
Add to research
Current Price
as of May 12, 2025$36.37
P/E Ratio
N/A
Market Cap
$3.57B
Description
Add to research
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Metrics
Add to research
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSRPT
- Price$36.37+0.28%
Trading Information
- Market cap$3.57B
- Float93.93%
- Average Daily Volume (1m)4,517,581
- Average Daily Volume (3m)3,088,293
- EPS-$2.52
Company
- Revenue$2.23B
- Rev growth (1yr)80.15%
- Net income-$447.51M
- Gross margin80.19%
- EBITDA margin-38.46%
- EBITDA-$286.47M
- EV$7.03B
- EV/Revenue3.15
- P/EN/A
- P/S1.59
- P/B3.13
- Debt/Equity117.59
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia